Depression

Columns

•SSRIs Deemed Safe During Pregnancy in Two Major Studies

•Promising Findings on Using Neuroimaging to Predict Treatment Response in Unipolar Depression

•SSRI Augmentation with Raloxifene for Partially Improved Depression

•Bacteria, Serotonin, and Depression: A Possible New Approach to Treating Mood Disorders

•Dopamine as a Pharmacological Target for Depression Treatment

•AAGP Report

•Sequenced Treatment Alternatives to Relieve Depression: Recent Results

•Monitoring SSRI-Treated Patients for Weight Gain and Cholesterol Elevation

•Psychopharmacology Research Tutorial

•Trends in Psychopharmacology

•Algorithm Updates—Major Depressive Disorder (MDD)

Feature Articles

•Clinical Predictors in Major Depressive Disorder

•Familial and Lifetime Associations of Childhood Functional Abdominal Pain

•Fatigue in Cancer Patients and Survivors: Mechanisms and Treatment

•The Stress Axis Gone Awry: A Possible Neuroendocrine Explanation for Increased Risk of Completed Suicide

•Treatment Options in Treatment-Resistant Depression

•Electroconvulsive Therapy in Treatment-Resistant Depression

•Neuroimaging and Depression with Inadequate Treatment Response

•Focal Brain Stimulation For Treatment–Resistant Depression: Transcranial Magnetic Stimulation, Vagus-Nerve Stimulation, and Deep-Brain Stimulation

•Treatment-Resistant Depression: An Overview of the Problem

•Vagus Nerve Stimulation: A New Tool for Treating Depression

•The Aims and Design of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study

Weekly Dispatches

•High BMI Score and Depression Treatment

•Suicide Attempts: Time Patterns Before and During Treatment

•Sibling Relationships: Predictor of Adult Depression?

•SSRIs and Birth Defects: Small Risk

•FDA Advisory on Suicidality: Linked With Decline in Treatment of Pediatric Depression?

•Pediatric Depression Diagnoses Drop

•Children with Mental Health Issues: Is There a Public Stigma?

•Depression Treatment: Effect on Gait and Cognitive Function

•Prevalence of Pubescent Self-Harm

•Recognizing Facial Expressions: Neural Correlates of Depression

•Low Birth Weight: Predictor of Depression?

•Shame in Female Borderline Patients: Implicit and Explicit

•Neuroticism and Depression in the Elderly

•Cannabis and Young Adult Depression

•Anxiety, Depression, Hostility: Cardiovascular Antagonists?

•Elderly Heart Failure and Confusion

•Cerebral Blood Flow Changes: An Explanation for ECT?

•Late-Life Depression in Rural and Urban Residents

•Anthroposophic Therapy Shows Promise in Chronic Depression

•Treating Depression in Diabetics: Cost-Effective?

•Link Between Paraoxonase Polymorphism and Depression Not Specific to Veterans and Sheep Dippers

•Lack of Perspective in New Suicidality Warning for Antidepressants

•A Bright Approach to SAD

•Weak Link Between SSRIs and Suicide

•Reducing the Risk of Late-Life Suicide Through Improved Depression Care

•Post-Stroke Depression: How Does it Impact Healthcare Use?

•Pharmacodynamic DDIs: Ach, GABA, and Others

•Treating Late-Life Depression

•Binge Eating & Depression: Predictors and Instigations

•Effects of Prior Antidepressant Use on Late-Life Treatment

•Altered Brain Chemistry in Women with MDD

•Venlafaxine Treatment of Interferon-α Induced Depression

•Psychiatric Drug Interactions

•Results from the STAR*D Study

•Depression and Social Self-Perceptions Linked

•Phobic Anxiety and Depression Predictors of Ventricular Arrhythmias

•Treatment-Resistant Depression and the Bipolar Spectrum: Recognition and Management

•Women, Drinking, and Depression: A Deadly Brew

•Scopolamine is a Rapid-Acting Antidepressant

•Older Men Less Likely to Receive Treatment for Depression

•Dopamine in Depressed Patients with Psychomotor Retardation

•Study Identifies Predictors for Antidepressant Treatment Response

•Antidepressant Discontinuation Syndrome

•Pregnant Women: Undertreated for Depression?

•Ketamine: The Speedy Antidepressant?

•STAR*D: The Third Drug’s the Charm

•Beyond the Survey: Epidemiology For the 21st Century

•FDA Approves First Generic Sertraline Tablets for Treatment of Major Depressive Disorder

•Children of Depressed Parents: More Prone to Psychiatric Disorders?

•Hitting a Nerve, Treating Refractory Depression

•Unlocking a Window: TMS for Refractory Depression

•Light Treatment and Fluoxetine Go Head to Head: Both Win

•Coping Strategies Important in Mood of Multiple Sclerosis Patients

•Editor’s Note: Anti-Inflammatory Actions of Antidepressants

•Benefits and Side Effects of the Selegeline Transdermal System

•fMRI May Predict Success of CBT

•Level 2 STAR*D: If at First You Don’t Remit...

•Here Today, Here Tomorrow: Adult Outcomes of Adolescent Depression

•Treatment of Bipolar I Disorder: Currently Depressed

•Diabetes and Depression Go Hand in Hand

•SSRI Failure Can Effectively Be Met by Switching to New SSRI

•Adolescent Depression Persists Into Adulthood

•Antidepressants and Pregnancy

•Depression and Anxiety Tied to Refractory Epilepsy Surgery

•Critical Care Givers Prone to Depression

•Heart Disease Inflammation Hastened by Depression